Clinical Implication of Very Low Dose of Sacubitril/valsartan for Patients With Heart Failure With Reduced Ejection Fraction; Beyond PARADIGM-HF and PIONEER-HF Trial

被引：0
|
作者：
Kim, Hyoeun
Oh, Jaewon
Ha, Jaehyung
Chun, Kyeong-Hyeon
Lee, Chan Joo
Park, Sungha
Lee, Sang-Hak
Kang, Seok-Min
机构：
来源：
CIRCULATION | 2019年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10616
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Safety and tolerability of sacubitril/valsartan in chronic heart failure and reduced ejection fraction: Results from the open-label extension of the PARADIGM-HF study
    Senni, Michele
    Paruchuru, Pratap
    Shi, Victor
    Boehm, Michael
    EUROPEAN JOURNAL OF HEART FAILURE, 2025,
  • [22] EFFECT OF SACUBITRIL/VALSARTAN ON BIOMARKERS OF MYOCARDIAL STRESS IN PATIENTS HOSPITALIZED WITH ACUTE HEART FAILURE IN PIONEER-HF
    Morrow, David A.
    Velazquez, Eric
    DeVore, Adam
    Duffy, Carol I.
    Prescott, Margaret
    McCague, Kevin
    Rocha, Ricardo
    Braunwald, Eugene
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 682 - 682
  • [23] Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial
    Berg, David D.
    Samsky, Marc D.
    Velazquez, Eric J.
    Duffy, Carol I.
    Gurmu, Yared
    Braunwald, Eugene
    Morrow, David A.
    DeVore, Adam D.
    CIRCULATION-HEART FAILURE, 2021, 14 (02) : E007034
  • [24] Comparison of Angioedema in Heart Failure Patients Treated with Sacubitril/Valsartan or Enalapril in the PARADIGM-HF Study
    Kaplan, Alan
    Streefkerk, Hendrik
    Thorburn, Christine
    Shi, Victor
    Zhou, Wenchun
    Schwende, Heike
    Packer, Milton
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (08) : S66 - S67
  • [25] Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study
    Jain, Anil Ranjeetmal
    Aggarwal, Rakesh Kumar
    Rao, Nanyam Srinivas
    Billa, Gauri
    Kumar, Shankar
    INDIAN HEART JOURNAL, 2020, 72 (06) : 535 - 540
  • [26] PIONEER-HF: a new frontier in the role of neprilysin inhibition in the management of heart failure with reduced ejection fraction
    Docherty, Kieran F.
    McMurray, John J. V.
    CARDIOVASCULAR RESEARCH, 2019, 115 (13) : E136 - E139
  • [27] Representativeness of the PIONEER-HF Clinical Trial Population in Patients Hospitalized with Heart Failure
    Sayeed, Sabina
    Fudim, Marat
    Xu, Haolin
    Matsouaka, Roland
    Heidenreich, Paul A.
    Yancy, Clyde W.
    Fonarows, Gregg C.
    Velazquez, Eric J.
    Hernandez, Adrian F.
    DeVore, Adam D.
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S151 - S151
  • [28] Sacubitril/valsartan: from the PARADIGM-HF trial results to heart failure patients in internal medicine. A narrative review
    Verdiani, Valerio
    ITALIAN JOURNAL OF MEDICINE, 2021, 15 (01) : 17 - 26
  • [29] Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial
    Vardeny, Orly
    Claggett, Brian
    Kachadourian, Jessica
    Desai, Akshay S.
    Packer, Milton
    Rouleau, Jean
    Zile, Michael R.
    Swedberg, Karl
    Lefkowitz, Martin
    Shi, Victor
    McMurray, John J. V.
    Solomon, Scott D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (03) : 337 - 341
  • [30] Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure A Secondary Analysis of the PARADIGM-HF Trial
    Chandra, Alvin
    Lewis, Eldrin F.
    Claggett, Brian L.
    Desai, Akshay S.
    Packer, Milton
    Zile, Michael R.
    Swedberg, Karl
    Rouleau, Jean L.
    Shi, Victor C.
    Lefkowitz, Martin P.
    Katova, Tzvetana
    McMurray, John J., V
    Solomon, Scott D.
    JAMA CARDIOLOGY, 2018, 3 (06) : 498 - 505
12345